In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

Thanks to a series of equity and debt offerings, Insulet has managed to buy time in the race to expand its sales base and reach profitability before running out of cash. As of the end of December, ...